Thermo Fisher acquires Novasep’s viral vector manufacturing business
With the acquisition, Thermo Fisher will expand its manufacturing capabilities for cell and gene therapies
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
18 Jan 21
With the acquisition, Thermo Fisher will expand its manufacturing capabilities for cell and gene therapies
12 Jan 21
The collaboration will help Novartis expand its oncology portfolio with late-stage PD-1 for monotherapy and potential PD-1 combinations
08 Jan 21
The acquisition of AmpTec will allow Merck to strengthen its capabilities in developing and manufacturing mRNA, used in…
07 Jan 21
The new manufacturing site for biopharmaceuticals will offer an end-to-end single-site solution from drug substances to fill-finish and…
22 Sep 20
Samsung Biologics will offer large-scale commercial manufacturing in its Plant 3 along with drug product to support AstraZeneca's…
10 Aug 20
Pfizer is expected to provide manufacturing services from its McPherson, Kansas facility to manufacture and supply Gilead’s remdesivir
24 Jul 20
Novavax has already started manufacturing the first batch of its NVX-CoV2373 at FDB's manufacturing facility in Morrisville, North…
25 May 20
Despite the rapid growth in demand for drugs, the pharma industry has not kept pace - meaning it…
Pharmaceuticals and MedicinesContract ManufacturingPharmaceuticals
Analysts at GlobalData believe the decrease in FDA drug approvals is due to a US government shutdown in…
06 Apr 20
Samsung will provide the full scope of its CDO services including cell line development, process development, cGMP clinical…